Status:
ACTIVE_NOT_RECRUITING
A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Conditions:
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Eligibility:
All Genders
Brief Summary
This is an observational study aimed at assessing if a new and specific heterozygous deletion detected at PKD2 gene is associated to a "founder effect" in 10 Autosomal dominant polycystic kidney disea...
Detailed Description
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited disease of the kidney. It occurs in adulthood but is also rarely diagnosed in early childhood. The majority of the dis...
Eligibility Criteria
Inclusion
- Patients with ADPKD
Exclusion
- Healthy patients
Key Trial Info
Start Date :
October 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06594367
Start Date
October 12 2024
End Date
October 1 2025
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Centre for Rare Diseases Aldo e Cele Daccò
Ranica, BG, Italy, 24020